|
|
|
|
The HKSAR courts' vulnerable judicial supremacy --
|
2014
|
1
|
|
|
HKScan Corporation MarketLine Company Profile
|
|
1
|
|
|
HKU Press law series
|
|
2
|
|
|
HKU Press law series.
|
|
17
|
|
|
HKUL book talk
|
|
3
|
|
|
HL
|
2004-
|
1
|
|
|
HL Display AB MarketLine Company Profile
|
|
1
|
|
|
HL7 Accelerator in Action --
|
2014
|
1
|
|
|
HL7 Advanced Topics --
|
2014
|
1
|
|
|
HL7 and Interchange Formats --
|
2012
|
1
|
|
|
HL7 Basic Message Construction Rules --
|
2014
|
1
|
|
|
HL7 Definitions -- / Appendix 2
|
2014
|
1
|
|
|
HL7 Dynamic Model --
|
2012
|
1
|
|
|
HL7 for BizTalk
|
2014
|
1
|
|
|
HL7 in the real-world -- / 3.
|
2015
|
1
|
|
|
HL7 Message --
|
2014
|
1
|
|
|
HL7 Message Encoding --
|
2014
|
1
|
|
|
HL7 V2 Segments to CDA Elements --
|
2014
|
1
|
|
|
The HL7 V3 RIM --
|
2012
|
1
|
|
|
Principles of health interoperability HL7 and SNOMED /
|
2012
|
1
|
|
|
HL7 for BizTalk /
|
2014
|
1
|
|
|
HL7 for BizTalk /
|
2014
|
1
|
|
|
HL7 for BizTalk /
|
2014
|
1
|
|
|
HL7 for BizTalk /
|
2014
|
1
|
|
|
HL7 Versions --
|
2014
|
1
|
|
|
HLA
|
2016
|
1
|
|
|
HLA Allele and Haplotype Frequencies of the Portuguese Bone Marrow Donors Registry / / Ricardo São João [and others] --
|
2013
|
1
|
|
|
The HLA and ABO Systems in the View of Stem Cell Transplant (HLA Typization: Choice of Donors) --
|
2013
|
1
|
|
|
HLA and Disease : a Comprehensive Review
|
2017
|
1
|
|
|
HLA and immunogenetics in cord blood transplantation /
|
|
2
|
|
|
HLA antibody detection and characterization by solid phase immunoassays : methods and pitfalls / / Andrea A. Zachary, Renato M. Vega, Donna P. Lucas, and Mary S. Leffell --
|
2012
|
1
|
|
|
HLA-B and HLA-C Supratyping by Pyrosequencing® / / Vanni, Irene (and others) --
|
2015
|
1
|
|
|
HLA class I and class II-induced intracellular signaling and molecular associations in primary human endothelial cells / / Nicole Valenzuela, Nwe Nwe Soe, Fang Li, Xiaohai Zhang, Yi-Ping Jin, and Elaine F. Reed --
|
2018
|
1
|
|
|
HLA class I and II matching improves prognosis in penetrating normal-risk keratoplasty / / T. Reinhard et al --
|
2003
|
1
|
|
|
HLA Class I Expression in Human Cancer --
|
2013
|
1
|
|
|
HLA Collaborative Simulation Oriented Virtual Machine Task Scheduling Strategy / / Zhiyun Ren, Xiao Song, Lin Zhang and Shaoyun Zhang --
|
2012
|
1
|
|
|
HLA
|
2016
|
1
|
|
|
HLA DR-DQ genotyping by capillary electrophoresis for risk assessment for celiac disease / / Ewa H. Lavant and Joyce Carlson
|
2013
|
1
|
|
|
The HLA factsbook
|
2000
|
1
|
|
|
HLA from benchtop to bedside
|
2021
|
1
|
|
|
HLA-G as an inhibitor of immune responses / / Aifen Lin and Wei-Hua Yan --
|
2016
|
1
|
|
|
HLA genotyping : methods for the identification of the HLA-DQ2,-DQ8 heterodimers implicated in celiac disease (CD) susceptibility / / Maria Edvige Fasano, Ennia Dametto, and Sandra D'Alfonso --
|
2015
|
1
|
|
|
HLA haplotype frequency estimation from real-life data with the Hapl-o-Mat software / / Jürgen Sauter, Christian Schäfer, and Alexander H. Schmidt
|
2018
|
1
|
|
|
HLA (Human Leucocyte-Associated) Class I Antigens on Red Cells -- / 33.
|
2013
|
1
|
|
|
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
|
2016
|
1
|
|
|
HLA matching --
|
2011
|
1
|
|
|
HLA news
|
2003-
|
1
|
|
|
HLA-peptide tetrameric complexes / / Graham S. Ogg --
|
2000
|
1
|
|
|
HLA Proxy: Towards Connecting Agents to Virtual Environments by Means of High Level Architecture (HLA) / / Tomas Plch, Tomas Jedlička, Cyril Brom --
|
2013
|
1
|
|
|
The HLA system --
|
2011
|
1
|
 Add Marked to Bag
Add All On Page
 Add Marked to My Lists
|